WinstonWınston
Back
Utah Medical Products logo

Utah Medical Products

UTMD
51
Medical - Instruments & Supplies · Healthcare
Exchange
NASDAQ
Winston Score
51
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Strong
Growth
Weak
Cash Flow
Exceptional
Stability
Good
Valuation
Mixed
Dividends
Weak

Winston Score History

The full picture

Utah Medical Products (UTMD) makes specialized medical devices used during childbirth and in hospitals. Its core products include tools for monitoring babies and mothers during labor, devices for managing blood flow, and neonatal care equipment. The company sells mainly to hospitals and healthcare providers, focusing on a narrow but essential slice of obstetrics and critical care.

UTMD earns revenue by selling its disposable and reusable medical devices directly and through distributors. It operates primarily in the United States but also sells internationally, including in Europe through its Femcare subsidiary. The company is small, with a market cap around $200 million, but it holds strong positions in niche product categories where switching costs and regulatory barriers limit competition. The main risk is its narrow product focus — if hospital purchasing shifts or a larger competitor enters its core markets, growth could stall.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
55.6%
Premium pricing power — 55.6% gross margin
Profit after running costs
Operating Margin
31.2%
Excellent — 31.2% operating margin
Return on the money invested
ROCE
8.4%
Below par — 8.4% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-7.0%
Shrinking sales (-7.0% YoY)
Profit growth
EPS YoY
-13.4%
Earnings shrinking (-13.4% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
127%
Turns 127% of profit into real cash
Spare cash per sale
FCF Margin
36.1%
Converts sales into free cash efficiently (36.1%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
100.00x
Comfortably covers interest (100.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
21.8x
no trend
Growth-priced — P/E 21.8

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
1.75%
no trend
Small dividend — 1.75% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+1.6%
no trend
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial